TherapeuticsMD (TXMD) Shares Outstanding (2010 - 2026)

TherapeuticsMD (TXMD) has reported Shares Outstanding (Entity) for 17 consecutive years, with $11.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) changed 0.0% year-over-year to $11.6 million; the trailing twelve-month figure through Jun 2026 stood at $11.6 million (changed 0.0% YoY), and the FY2025 full-year result was $11.6 million, changed 0.36% from the prior year.
• Shares Outstanding (Entity) steadied at $11.6 million in Q2 2026 per TXMD's latest filing, from $11.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $11.6 million in Q1 2025 and bottomed at $8.7 million in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $10.7 million across 5 years, with a median of $11.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) slumped 97.8% in 2022, then climbed 21.42% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $9.5 million in 2022, then advanced by 21.42% to $11.5 million in 2023, then changed by 0.0% to $11.5 million in 2024, then advanced by 0.36% to $11.6 million in 2025, then changed by 0.0% to $11.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $11.6 million, $11.6 million, and $11.6 million for Q2 2026, Q4 2025, and Q3 2025 respectively.